Agibot (Zhiyuan Robotics), one of China's leading embodied-AI companies, is raising a new funding round of 1 billion to 1.5 billion yuan at a valuation of roughly 50 billion yuan, and has delayed its planned year-end listing in Hong Kong, Chinese and overseas industry media reported on October 20.
The funding push comes as the sector's center of gravity visibly shifts. At the China International Industry Fair in Shanghai, humanoid robot makers dropped the fighting rings and sprint tracks of past years in favor of factory-floor demos: a Unitree G1 moving parcel boxes to marked spots, another tightening screws with an electric driver. Real production-line demand — mixed-model deployments of different robot forms on the same line, and reusable general-purpose "brain" capabilities decoupled from specific bodies — is now steering product roadmaps.
Investors appear to be rewarding the pivot toward useful work over spectacle. With China's humanoid industry expected to top 100,000 units of annual output, backers are betting that companies able to prove reliable, revenue-generating deployments will justify premium valuations even as the IPO window waits.
Source: Industry media roundup, October 20, 2026
